Châtillon, France, le 25 avril 2024 The post Assemblée Générale Mixte du 16 mai 2024 appeared first on Bio Tech Winners ..read more

Châtillon, France, April 25, 2024 The post Combined General Meeting of May 16, 2024 appeared first on Bio Tech Winners ..read more

Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced the publication of its 2024 Extra-Financial Performance Report (fiscal year 2023). The post GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) appeared first on Bio Tech Winners ..read more

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 25 avril 2024 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le pronostic vital, annonce aujourd’hui la publication de son rapport de performance extra-financière 2024 (exercice 2023). The post GENFIT : Publication du rapport de performance extra-financière 2024 (exercice 2023) appeared first on Bio Tech Winners ..read more

- Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT - The post Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update appeared first on Bio Tech Winners ..read more

CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA®1. The intravenous formulation of TOFIDENCE has been recommended for approval for the treatment of moderate to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis and COVID-19. The post Biogen Receives Positive CHMP Opin ..read more

Longeveron to present at investor conference - Planet MicroCap Showcase - May 1, 2024. The post Longeveron to Present at the Planet MicroCap Showcase appeared first on Bio Tech Winners ..read more

In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also secreting immunoregulatory cytokines and identifying and eliminating autoreactive T cells that contribute to neuroinflammation. The post NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit appeared first on Bio Tech Winners ..read more

– Company creating de novo designed macrocycles with enhanced efficacy that precisely target disease biology The post Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles appeared first on Bio Tech Winners ..read more

CARBIOS feiert gemeinsam mit seinen Partnern die Grundsteinlegung für seine weltweit erste PET-Biorecycling-Anlage The post CARBIOS feiert gemeinsam mit seinen Partnern die Grundsteinlegung für seine weltweit erste PET-Biorecycling-Anlage appeared first on Bio Tech Winners ..read more